BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
A soft launch, an unfollow and a lot of questions: Breaking down the 'Summer House' romance blowing up group chats - 2Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
- 3Mom finds out she has cancer after noticing something was off while breastfeeding
- 4Nutrient Rich Natural products: Lift Your Wellbeing
- 5Blake Lively's sexual harassment claims against Justin Baldoni dismissed. Where the case stands now.
- Vote In favor of Your Favored Treat
- Get To Be familiar with The Historical backdrop Of Western Medication
- First Greenland, now Iceland? Annexation joke by Trump ally gets frosty response in the Arctic nation.
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- Scientists uncover an ant assassination scheme that helps a parasitic queen rise to power
- Los Angeles County sees significant uptick in norovirus cases, officials say
- Instructions to Construct an Organization While Chasing after a Web-based Degree
- Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- Europe could get 42 more days of summer by the year 2100 due to climate change
